Pharmaceutical Transparency & Rational Prescribing

Bridging the medication
transparency gap.

In much of the world, doctors prescribe from memory under pressure, and patients leave without understanding what they are given or why. We are building tools to change that.

Read more

The Problem

The Medication Transparency Gap

In well-resourced settings, doctors prescribe with support — instant access to verified facts and records, and time to verify and explain.

Yet, in much of the world, these are luxuries: doctors have minutes to assess, decide from memory and habit, and leave patients to comply without question.

They work under constant pressure: high patient volume, limited information, and no time to pause, check, or explain.

Patients experience fear, urgency, and asymmetry — they leave with prescriptions, without understanding what they are given or why, and without the ability to question it.

They lack clarity on what the medicine is, why it is needed, what it costs, or what risks it carries.

The system reinforces opacity: brands mask drug identity, claims about unregulated drugs cannot be verified, and complexity masquerades as quality.

The predictable result: unsafe prescribing that drives higher costs and erodes adherence and trust.

These outcomes are not isolated — they reinforce each other.

Doctors and patients act rationally within these constraints — so the system stabilizes around information asymmetry.

The Need & Vision

The gap is not more information — both doctors and patients need information that is accessible, actionable, and available at the moment decisions are made.

Fix that — and quality, cost, adherence, and trust improve as a consequence.

The Tools

SageScript Tools

Two tools built for the same problem from both sides of the prescription.

In Development

For Doctors

Clinical Decision Support

A clinical decision tool for prescribing.

  • Ask focused questions — dosing, safety, interactions — and get concise, decision-ready answers in seconds.
  • Resolves brand names to exact composition, strength, and formulation before answering.
  • Delivers structured guidance aligned to clinical tasks — not long-form reference.
  • Deterministic, structured, and traceable by design.
  • Designed for voice, mobile, and messaging, within existing workflows.

In development.

For Patients

Medication Literacy Tool

A tool to understand and manage medicines.

  • Capture prescriptions, identify medicines, and see clearly what is being taken.
  • Organizes records into a persistent, searchable health history.
  • Highlights what matters — how to take medicines, what to watch for, and safer or lower-cost options.
  • Simple, structured, and easy to use.
  • Designed for shared use across families and caregivers, on mobile and messaging.

In development.

India's Prescribing Landscape

Ten Essential Facts

India's prescribing environment produces predictable, well-recognized harms — polypharmacy, irrational drug combinations, incomplete prescriptions, and unaffordable costs — not because of ignorance or malice, but because of structural choices. The problem is longstanding and has resisted change. Still, it is not inevitable.

These ten facts highlight the anatomy of dysfunction: a prescribing landscape shaped by structural incentives, regulatory gaps, and everyday constraints.

A failure of systems, not morals

Every actor in India's prescribing environment behaves rationally within a structure that produces harmful results. The dysfunction is built into the system — and systems can be changed.

I Scale — Volume Without Time
4 billion

Outpatient visits a year — averaging 2 minutes each

India exceeds 4 billion outpatient consultations annually, nearly four per person per year. Yet the average non-specialist consultation lasts approximately 2 minutes — compared with 20+ minutes in Sweden or Norway. In this window, deliberation is impossible. Prescribing becomes a rapid transactional act rather than a clinical decision. This is not a failure of individual effort; it is an arithmetic constraint built into a system that has never matched physician supply to patient load.

Scale & Workforce
19%

The proportion of rural prescribers with formal medical qualifications

WHO estimates that only 58% of urban doctors and 19% of rural doctors hold formal medical qualifications. In rural areas, up to 70% of medical visits occur with uncertified practitioners. These informal providers are not fringe actors — they are the de facto primary care system for hundreds of millions. Their prescribing relies on rote habit, brand recall, and patient demand rather than diagnosis-driven care.

Workforce
II Market Structure — Opacity by Design
360,000+

The estimated number of marketed drug brands

India markets more than 360,000 uniquely branded prescription products, vastly exceeding the actual number of distinct chemical entities. More than half contain two or more active substances. There is no centralized brand registry: companies self-certify that new names are not confusingly similar to existing ones. Similar-sounding names differing by one or two letters may represent entirely different drug classes — creating endemic medication-error risk largely invisible internationally.

Market Structure
6,000+

The number of unapproved drug ingredient combinations

India markets an estimated 6,000+ fixed-dose combinations (FDCs). The majority entered the market without central government review or authorization, often through state-level licensing gaps. Many had no clear therapeutic justification, yet remained on sale for years. The core problem is not simply that some combinations were later banned, but that such a large market was allowed to form in the first place.

Unapproved Fixed-Dose Combinations
~ 50%

The share of prescribed drugs subject to price controls

Under India's price control regime, single-ingredient drugs on the National Essential Medicines List face price ceilings. Pharmaceutical companies circumvent these by reformulating approved drugs into novel FDC combinations that fall outside price control jurisdiction. This creates a perverse incentive: the more therapeutically unjustified a combination, the more commercially attractive it becomes. Price regulation systematically fails to protect the patients who most need affordable medicines.

Price Controls
III Prescription Quality — Incomplete at the Point of Care
~ 40%

The share of prescriptions lacking required information

Even at India's top academic teaching hospitals, approximately 40% of prescriptions are missing critical elements — dose, duration, formulation, or indication. In government teaching hospitals, doctors prescribe more than three drugs per visit on average. With 2-minute consultations and no decision support, completeness is sacrificed to throughput. The consequences — wrong dose, preventable drug interactions, treatment failure — fall on patients who lack the information to detect the gap.

Prescription Quality
IV Access & Affordability — Price Controls Bypassed
~ 50%

The share of generics prescribed

Generic medicines are prescribed in fewer than half of Indian prescriptions. More strikingly, 75% of medicines prescribed are not on the National Essential Medicines List and face no price controls. Pharmaceutical detailing, branded samples, and commercial incentives systematically steer prescribers toward branded and combination products. The regulatory architecture of price control has been structurally outmaneuvered by market design.

Generic Underuse
~ 70%

The share of household health spending on medicines

Rural Indians spend 77% of total health expenditure on medicines; urban Indians approximately 70%. A single prescription can consume 3–4% of minimum monthly wages. Medication adherence for non-communicable diseases averages approximately 51%. Costly, complex, poorly explained regimens predictably fail — producing a cycle of treatment failure, repeat visits, and compounding cost.

Cost & Adherence
V Cultural Dynamics — Authority Without Accountability
~ 50%

Proportion of people reporting self-medicating

In India, roughly half of people report self-medicating — a sign not of patient empowerment, but of a system that normalizes medicine use without clinical guidance. Enabled by weak prescription enforcement, pharmacy-mediated consultation, and strong demand for quick relief, this pattern leaves patients making treatment decisions with limited information. The practical effect is to shift the burden of risk from the health system to the consumer.

Self-Medication
74%

Proportion of patients reporting trust in their doctors

In India, roughly 74% of people report trusting doctors, yet that trust often functions as deference rather than informed partnership. In clinical settings where doctors are treated as unchallengeable authorities, patients may hesitate to ask questions while still expecting immediate relief. The result is authority without accountability: high interpersonal trust coexists with low patient understanding, weak shared decision-making, and persistent pressure toward inappropriate prescribing.

High Trust, Low Agency

Irrational prescribing is not inevitable

Safe andevidence-based prescribring requires changes in workforce training, pharmaceutical regulation, price control design, and prescriber accountability.

Facts drawn from peer-reviewed literature, WHO reports, government regulatory data, and investigative sources (2016–2025). Sources include: BMJ Open, PLOS Medicine, Frontiers in Pharmacology, WHO, CDSCO, Pulitzer Center, and the Competition Commission of India.